Peter Reiss

50.6k total citations · 14 hit papers
504 papers, 30.6k citations indexed

About

Peter Reiss is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Peter Reiss has authored 504 papers receiving a total of 30.6k indexed citations (citations by other indexed papers that have themselves been cited), including 320 papers in Infectious Diseases, 231 papers in Emergency Medicine and 223 papers in Virology. Recurrent topics in Peter Reiss's work include HIV-related health complications and treatments (231 papers), HIV/AIDS drug development and treatment (224 papers) and HIV Research and Treatment (222 papers). Peter Reiss is often cited by papers focused on HIV-related health complications and treatments (231 papers), HIV/AIDS drug development and treatment (224 papers) and HIV Research and Treatment (222 papers). Peter Reiss collaborates with scholars based in Netherlands, United Kingdom and United States. Peter Reiss's co-authors include Timothy F. Bresnahan, Jens Lundgren, Antonella d’Arminio Monforte, Ole Kirk, Caroline Sabin, Andrew Phillips, Rainer Weber, Wafaa El‐Sadr, Matthew Law and Nina Friis‐Møller and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter Reiss

485 papers receiving 29.4k citations

Hit Papers

Antiretroviral Treatment of Adult... 1991 2026 2002 2014 2012 2002 2003 1991 2008 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antiretroviral Treatment of Adult HIV Infection
    2012 1.4k citations Peter Reiss et al. profile →
  2. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
    2002 1.2k citations Andrew Phillips, Bruno Ledergerber et al. profile →
  3. Decline in the AIDS and death rates in the EuroSIDA study: an observational study
    2003 989 citations Amanda Mocroft, Bruno Ledergerber et al. profile →
  4. Entry and Competition in Concentrated Markets
    1991 942 citations Peter Reiss et al. profile →
  5. Antiretroviral Treatment of Adult HIV Infection
    2008 832 citations Peter Reiss et al. profile →
  6. Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
    2003 802 citations Nina Friis‐Møller, Peter Reiss et al. AIDS profile →
  7. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
    2014 689 citations Peter Reiss, Justyna Kowalska et al. profile →
  8. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
    1999 677 citations Kees Brinkman, Peter Reiss et al. profile →
  9. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
    2008 675 citations Caroline Sabin, Peter Reiss et al. profile →
  10. Antiretroviral Treatment of Adult HIV Infection
    2010 595 citations Huldrych F. Günthard, Peter Reiss et al. profile →
  11. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
    2008 519 citations Peter Reiss, Robert Colebunders et al. profile →
  12. Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
    2009 481 citations Caroline Sabin, Peter Reiss et al. The Journal of Infectious Diseases profile →
  13. Antiretroviral Treatment of Adult HIV Infection
    2014 352 citations Huldrych F. Günthard, Peter Reiss et al. profile →
  14. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis
    2014 307 citations Nienke Langebeek, Elizabeth H. Gisolf et al. BMC Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Reiss Netherlands 84 18.7k 12.6k 12.2k 7.6k 2.2k 504 30.6k
Michael D. Hughes United States 69 7.1k 0.4× 2.0k 0.2× 5.3k 0.4× 2.4k 0.3× 667 0.3× 281 17.1k
David Vlahov United States 107 14.4k 0.8× 3.2k 0.3× 8.5k 0.7× 19.7k 2.6× 870 0.4× 672 46.6k
Edward J. Mills Canada 80 8.4k 0.5× 2.0k 0.2× 2.5k 0.2× 4.9k 0.6× 2.2k 1.0× 350 22.8k
Stephen J. Gange United States 59 8.1k 0.4× 3.4k 0.3× 6.9k 0.6× 4.3k 0.6× 355 0.2× 237 17.3k
Milton C. Weinstein United States 94 4.8k 0.3× 1.4k 0.1× 1.8k 0.1× 6.2k 0.8× 11.8k 5.3× 354 33.8k
Miguel A. Hernán United States 93 5.8k 0.3× 1.2k 0.1× 879 0.1× 4.4k 0.6× 5.8k 2.6× 313 42.2k
James M. Robins United States 88 2.9k 0.2× 1.0k 0.1× 716 0.1× 3.8k 0.5× 8.2k 3.7× 285 44.6k
Stephen R. Cole United States 72 3.3k 0.2× 1.6k 0.1× 1.2k 0.1× 3.8k 0.5× 2.1k 0.9× 447 23.2k
Till Bärnighausen United States 70 7.8k 0.4× 1.1k 0.1× 1.5k 0.1× 5.3k 0.7× 3.0k 1.3× 638 19.4k
John Kaldor Australia 83 8.6k 0.5× 948 0.1× 2.9k 0.2× 13.7k 1.8× 712 0.3× 712 28.0k

Countries citing papers authored by Peter Reiss

Since Specialization
Citations

This map shows the geographic impact of Peter Reiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Reiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Reiss more than expected).

Fields of papers citing papers by Peter Reiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Reiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Reiss. The network helps show where Peter Reiss may publish in the future.

Co-authorship network of co-authors of Peter Reiss

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Reiss. A scholar is included among the top collaborators of Peter Reiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Reiss. Peter Reiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wit, Ferdinand W.N.M., Vita W. Jongen, Kees Brinkman, et al.. (2025). Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk. Clinical Infectious Diseases.
2.
Blenkinsop, Alexandra, Evangelia Georgia Kostaki, Ard van Sighem, et al.. (2024). Sources of Human Immunodeficiency Virus Infections Among Men Who Have Sex With Men With a Migration Background: A Viral Phylogenetic Case Study in Amsterdam, The Netherlands. The Journal of Infectious Diseases. 230(4). e881–e894.
3.
Esteban-Cantos, Andrés, Christian Thorball, Berta Rodés, et al.. (2023). Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years. The Lancet Healthy Longevity. 4(5). e211–e218. 21 indexed citations
4.
Alagaratnam, Jasmini, Davide De Francesco, Henrik Zetterberg, et al.. (2021). Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study. Journal of NeuroVirology. 28(1). 54–63. 14 indexed citations
5.
Davis, Katherine, Pablo N. Perez‐Guzman, Annika Hoyer, et al.. (2021). Association between HIV infection and hypertension: a global systematic review and meta-analysis of cross-sectional studies. BMC Medicine. 19(1). 105–105. 34 indexed citations
6.
7.
Rokx, Casper, Colette Smit, Ferdinand W.N.M. Wit, et al.. (2020). Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study. PLoS Medicine. 17(5). e1003101–e1003101. 21 indexed citations
8.
Gow, Ian D., David F. Larcker, & Peter Reiss. (2016). Causal Inference in Accounting Research. RePEc: Research Papers in Economics. 1 indexed citations
9.
Smit, Colette, Ard van Sighem, Peter Reiss, et al.. (2015). Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the Netherlands. AIDS. 30(2). 301–310. 10 indexed citations
10.
Langebeek, Nienke, Elizabeth H. Gisolf, Peter Reiss, et al.. (2014). Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Medicine. 12(1). 142–142. 307 indexed citations breakdown →
11.
Boer, Kimberly R., et al.. (2013). Long-term Effectiveness of Combination Antiretroviral Therapy and Prevalence of HIV Drug Resistance in HIV-1–infected Children and Adolescents in Rwanda. The Pediatric Infectious Disease Journal. 33(1). 63–69. 35 indexed citations
12.
Kowalska, Justyna, Nina Friis‐Møller, Ole Kirk, et al.. (2011). The Coding Causes of Death in HIV (CoDe) Project. Epidemiology. 22(4). 516–523. 111 indexed citations
13.
Peters, Lars, Amanda Mocroft, Vincent Soriano, et al.. (2009). Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(5). 457–463. 34 indexed citations
14.
Casula, Miriam, Gerrit Jan Weverling, Ferdinand W.N.M. Wit, et al.. (2005). Mitochondrial DNA and RNA Increase in Peripheral Blood Mononuclear Cells from HIV‐1–Infected Patients Randomized to Receive Stavudine‐Containing or Stavudine‐Sparing Combination Therapy. The Journal of Infectious Diseases. 192(10). 1794–1800. 36 indexed citations
15.
Friis‐Møller, Nina, Ole Kirk, Peter Reiss, et al.. (2003). Safety of non-nucleoside reverse transcriptase therapy: data from the EuroSIDA study. UCL Discovery (University College London). 1 indexed citations
16.
Mocroft, Amanda, Lı́dia Ruiz, Peter Reiss, et al.. (2003). Virological rebound after suppression on highly active antiretroviral therapy. AIDS. 17(12). 1741–1751. 91 indexed citations
17.
Clumeck, Nathan, Stéphane De Wit, Philippe Hermans, et al.. (2003). European guidelines for the clinical management and treatment of HIV-infected adults in Europe. AIDS. 17. 43 indexed citations
18.
Wout, J.W. van ’t, Bart Jan Kullberg, Jacques F. Meis, & Peter Reiss. (1995). Schimmelinfecties bij patienten met een gestoorde afweer.. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 139(28). 1430–1436.
19.
Reiss, Peter, Joep M. A. Lange, Anthony de Ronde, et al.. (1990). Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individuals.. PubMed. 3(2). 115–22. 20 indexed citations
20.
Reiss, Peter. (1980). Immigrant strategies : agricultural labor and the acquisition of land and status of the island of Djerba, Tunisia. UMI eBooks. 41(6). 2673–2674.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael D. Hughes Breakdown of academic impact, for papers by David Vlahov Breakdown of academic impact, for papers by Edward J. Mills Breakdown of academic impact, for papers by Stephen J. Gange Breakdown of academic impact, for papers by Milton C. Weinstein Breakdown of academic impact, for papers by Miguel A. Hernán Breakdown of academic impact, for papers by James M. Robins Breakdown of academic impact, for papers by Stephen R. Cole Breakdown of academic impact, for papers by Till Bärnighausen Breakdown of academic impact, for papers by John Kaldor
Rankless by CCL
2026